1. Home
  2. ANIX vs NAMM Comparison

ANIX vs NAMM Comparison

Compare ANIX & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

NAMM

Namib Minerals Ordinary Shares

HOLD

Current Price

$1.75

Market Cap

77.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
NAMM
Founded
1982
2024
Country
United States
Cayman Islands
Employees
N/A
1500
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
77.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ANIX
NAMM
Price
$2.74
$1.75
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
158.6K
1.6M
Earning Date
05-27-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
$76.84
Revenue Next Year
N/A
$85.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$0.91
52 Week High
$5.46
$11.63

Technical Indicators

Market Signals
Indicator
ANIX
NAMM
Relative Strength Index (RSI) 51.99 45.93
Support Level $2.38 $1.75
Resistance Level $3.12 $1.80
Average True Range (ATR) 0.19 0.16
MACD 0.04 -0.02
Stochastic Oscillator 61.54 8.16

Price Performance

Historical Comparison
ANIX
NAMM

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About NAMM Namib Minerals Ordinary Shares

Namib Minerals is a Pan-African multi-asset mining platform for precious and critical metals, particularly gold. The company is an established gold producer with an attractive portfolio of three gold mines in Zimbabwe, Africa. Its gold mines include How Mine, Mazowe Mine, and Redwing Mine. Its segments include the How Mine, the Mazowe Mine, and the Redwing Mine, and Others.

Share on Social Networks: